Actinium Pharmaceuticals, Inc.

ATNM · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$5-$7-$16-$7
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$9$1
Change in WC-$2$1-$1-$1
Other Non-Cash$0$0$0$0
Operating Cash Flow-$6-$5-$8-$6
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$0-$0-$0-$0
Stock Issued$0$0$0-$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0$0$0
Financing Cash Flow-$0-$0-$0-$0
Forex Effect-$0$0$0$0
Net Chg. in Cash-$7-$5-$8-$6
Supplemental Information
Beg. Cash$60$66$73$79
End Cash$53$60$66$73
Free Cash Flow-$6-$5-$8-$6
Actinium Pharmaceuticals, Inc. (ATNM) Financial Statements & Key Stats | AlphaPilot